GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 87 filers reported holding GALENA BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,000 | -26.7% | 31,755 | 0.0% | 0.00% | – |
| Q2 2016 | $15,000 | -65.1% | 31,755 | 0.0% | 0.00% | – |
| Q1 2016 | $43,000 | +7.5% | 31,755 | +16.1% | 0.00% | – |
| Q4 2015 | $40,000 | -7.0% | 27,360 | 0.0% | 0.00% | – |
| Q3 2015 | $43,000 | -46.9% | 27,360 | -30.6% | 0.00% | – |
| Q3 2014 | $81,000 | -31.4% | 39,418 | +2.2% | 0.00% | – |
| Q2 2014 | $118,000 | -8.5% | 38,563 | -25.5% | 0.00% | – |
| Q1 2014 | $129,000 | – | 51,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |